MainboardListed

Anthem Biosciences IPO - Listing Date, GMP & Subscription

Anthem Biosciences Ltd IPO listing date: Jul 21, 2025 on NSE, BSE. Listed at ₹864 (+51.4%) vs issue price of ₹570. Subscribed 113.15x overall (QIB: 197.69x). Price band: ₹540-₹570, lot size 26 shares.

sHQ

stoicHQ Research Team · Ex-quants, IIT Delhi · Updated Jul 20, 2025

Key Dates

IPO Open DateJul 14, 2025

IPO Close DateJul 16, 2025

Allotment DateJul 17, 2025

Refund DateJul 18, 2025

Demat Credit DateJul 18, 2025

Listing DateJul 21, 2025

Issue Details

Price Band₹540-₹570

Issue Price₹570

Face Value₹1

Lot Size26 shares

Min Investment₹14,820

Issue Size₹3,395 crore

Listing ExchangeNSE, BSE

RegistrarKFin Technologies

IPO TypeMainboard

stoicHQ Analysis

✓197x QIB subscription

✓51% listing gain

✓India biologics CDMO - China+1 beneficiary

✓Complex API and biologic manufacturing moat

⚠CDMO revenue is lumpy and milestone-dependent

⚠Customer concentration in early-stage pharma

About Anthem Biosciences Ltd

Anthem Biosciences is a leading CDMO for biologics, peptides, and complex APIs, serving global pharma majors across oncology and diabetes therapeutics.

Subscription Breakdown

Overall Subscription113.15x

QIB (Institutional)197.69x

NII (HNI)149.75x

Retail41.53x

Listing Price

₹864

Listing Gain

+51.4%

Issue Price

₹570

stoicHQ Analysis

Exceptional 51.4% listing gain driven by the global CDMO sector re-rating. QIB at 197x reflected unanimous institutional conviction in the biologics CDMO thesis. India CDMO has significant tailwind from China+1 supply chain shifts.

Pharmaceuticals / CDMO2025All 2025 IPOs

IPO Listing Timeline

Previous IPO← Aegis Vopak Terminals IPO (listed Jun 3, 2025)Next IPOIndiQube Spaces IPO (listed Aug 13, 2025) →

More IPOs from 2025

Quadrant Future Tek IPO+135.2%Laxmi Dental IPO+114.0%Hexaware Technologies IPO-7.1%

Anthem Biosciences IPO GMP - Historical Grey Market Premium

GMP is an unofficial market price. For educational purposes only.

DateGMP (₹)KostakImplied Gain

Jul 20, 2025+₹294-+51.6%

Jul 18, 2025+₹290-+50.9%

Jul 16, 2025+₹280₹2400+49.1%

Jul 14, 2025+₹260₹2200+45.6%

Jul 12, 2025+₹240₹2000+42.1%

Jul 10, 2025+₹200₹1600+35.1%

Jul 8, 2025+₹140₹1200+24.6%

Anthem Biosciences IPO Subscription Status - Day Wise

DayOverallQIBNII (HNI)Retail

Day 1 (Jul 14)14.20x3.18x11.42x17.64x

Day 2 (Jul 15)51.88x47.32x62.18x35.20x

Day 3 (Jul 16)113.15x197.69x149.75x41.53x

Anchor Investors

Fidelity Funds₹185 crore

Government Pension Fund Global (Norway)₹170 crore

SBI Mutual Fund₹150 crore

HDFC Mutual Fund₹140 crore

Kotak Mutual Fund₹120 crore

Anthem Biosciences Ltd - Financials at IPO

YearRevenuePATNet Margin

FY22₹892 crore₹185 crore20.7%

FY23₹1,105 crore₹248 crore22.4%

FY24₹1,320 crore₹312 crore23.6%

Listed Peers - Pharmaceuticals / CDMO

Syngene InternationalCDMO / Contract Research

Divi's LaboratoriesAPI / CDMO

Sai Life SciencesCDMO

+35.0% listing

Frequently Asked Questions

When did Anthem Biosciences IPO list?

Anthem Biosciences IPO listed on July 21, 2025 on NSE and BSE at ₹864, a 51.4% gain over the issue price of ₹570.

What is the Anthem Biosciences IPO GMP today?

Anthem Biosciences is now listed and there is no active grey market for this IPO. The GMP (grey market premium) peaked at ₹290-₹294 before listing, correctly forecasting the 51.4% listing gain on July 21, 2025.

What was the Anthem Biosciences IPO subscription status?

Anthem Biosciences IPO was subscribed 113.15x overall. QIB subscription was exceptional at 197.69x, NII (HNI) was 149.75x, and retail was 41.53x. Day 1 subscription was 14.20x, Day 2 was 51.88x, and Day 3 was 113.15x.

What is Anthem Biosciences and what does it do?

Anthem Biosciences is a CDMO (Contract Development and Manufacturing Organisation) focused on biologics, peptides, and complex APIs. It serves global pharmaceutical companies in oncology and diabetes. It is a key beneficiary of the China+1 supply chain shift in pharma manufacturing.

What is the allotment date for Anthem Biosciences IPO?

The allotment date for Anthem Biosciences IPO was July 17, 2025. Refunds were processed on July 18, 2025 and demat credit was on July 18, 2025. Listing was on July 21, 2025.

What is the price band for Anthem Biosciences IPO?

The price band for Anthem Biosciences IPO was ₹540-₹570 per share. The lot size was 26 shares, with minimum investment of ₹14,820 at the upper price band. The issue size was ₹3,395 crore.

Who was the registrar for Anthem Biosciences IPO?

KFin Technologies was the registrar for Anthem Biosciences IPO. To check allotment status, visit kosmos.kfintech.com/ipostatus, select Anthem Biosciences, and enter your PAN or application number.